Having trouble accessing articles? Reset your cache.

Democrats, Republicans use marathon hearing to preview 2020 drug pricing debates

Republicans say H.R. 3 will kill innovation, Democrats say cuts are a drop in the ocean

During an eight-hour Energy & Commerce hearing on Oct. 17, Democrats and Republicans previewed and rehearsed arguments about drug pricing that they will be making in town hall meetings and stump speeches across the country next year.

Republicans prolonged the hearing to highlight their support for alternative drug pricing proposals, compel Democrats to vote against amendments that Republicans believe will resonate among voters, and reiterate the GOP’s contention that legislation crafted by House Speaker Nancy Pelosi (D-Calif.) will crush innovation.

Democrats painted Republicans as tools of big pharma and pointed out that many of the proposals Republicans denigrated are consistent with promises President Donald Trump has made.

The outcome of the hearing, a vote along party lines to send the Lower

Read the full word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers